Home › Research › Biomarkers
Blood biomarkers of frailty and cognition: A scoping review
Maddison L. Hodgins, Selena P. Maxwell, Susan E. Howlett, Ken Rockwood. Neurobiology of Aging, 2026-01-09
Topic: Risk, prevention and care in population studies
Plain-language summary
Frailty increasingly is recognized as a factor that modifies the relationship between disease biomarkers, including neuropathology, and dementia expression. The mechanisms underlying the relationship between frailty and dementia remain unclear, but blood biomarkers can offer insight into these mechanisms. We completed a scoping review of research examining the associations between blood biomarkers, frailty, and cognition. Three online databases were searched to identify original research examining blood biomarkers in the context of frailty and/or cognitive decline that accounted for the other condition in the analysis through stratification or inclusion in the model. Five of the 76 unique biomarkers identified —A disintegrin and Metalloproteinase 10 (ADAM10), fibrinogen, interleukin (IL)-6, neurofilament light chain (NfL) and vitamin D— were significantly and independently associated with both frailty and cognition. All five biomarkers could contribute to aging mechanisms, including disrupted proteostasis, chronic inflammation, dysregulated metabolism and/or deregulated nutrient sensing. These biomarkers could thus be common pathways of frailty and cognitive decline. Despite the Alzheimer-defining roles of β-amyloid and phosphorylated tau, these biomarkers typically are reported without considering the degree of frailty. Future biomarker research in cognitive decline and frailty should seek a clearer understanding of their relationship. • We reviewed 33 articles exploring blood biomarkers in frailty and cognitive decline • ADAM10, vitamin D, fibrinogen, IL-6, and NfL are altered in both processes • Most biomarkers were involved in inflammation and nutrient sensing • Most studies did not report coefficients/estimates for both frailty and cognition • Most studies were not interested in sex differences in blood biomarkers
What this study adds
Evidence grade: Low
This scoping review found five blood biomarkers linked to both frailty and cognition, suggesting shared aging pathways. It does not test any treatment or prevention, so it cannot show whether targeting these markers changes disease course.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hodgins, M. L., Maxwell, S. P., Howlett, S. E., & Rockwood, K. (2026). Blood biomarkers of frailty and cognition: A scoping review. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2026.01.003
Vancouver
Hodgins ML, Maxwell SP, Howlett SE, Rockwood K. Blood biomarkers of frailty and cognition: A scoping review. Neurobiology of Aging. 2026. doi:10.1016/j.neurobiolaging.2026.01.003. PMID: 41544446.
BibTeX
@article{hodgins2026-41544446,
author = {Hodgins, Maddison L. and Maxwell, Selena P. and Howlett, Susan E. and Rockwood, Ken},
title = {{Blood biomarkers of frailty and cognition: A scoping review}},
journal = {Neurobiology of Aging},
year = {2026},
doi = {10.1016/j.neurobiolaging.2026.01.003},
pmid = {41544446},
url = {https://doi.org/10.1016/j.neurobiolaging.2026.01.003}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Five of the 76 unique biomarkers identified —A disintegrin and Metalloproteinase 10 (ADAM10), fibrinogen, interleukin (IL)-6, neurofilament light chain (NfL) and vitamin D— were significantly and independently associated with both frailty and cognition.
Why it matters
This scoping review found five blood biomarkers linked to both frailty and cognition, suggesting shared aging pathways. It does not test any treatment or prevention, so it cannot show whether targeting these markers changes disease course.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neurobiology of Aging) |
| Journal's citation record | 3 / 4 | Neurobiology of Aging: journal h-index 263 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 10 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 5 / 6 | Cited 39.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 10 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Ken Rockwood: h-index 11 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Dalhousie University: institution h-index 778 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41544446) |
| Free to read | 2 / 2 | Free to read |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.neurobiolaging.2026.01.003
- PubMed: 41544446
- Original source →
- Free full text: Neurobiology of Aging →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 19.
Related studies in Biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.